Human Genetics

, Volume 121, Issue 2, pp 155–160

Resequencing and association analysis of the SP110 gene in adult pulmonary tuberculosis

  • Jeffrey S. Szeszko
  • Barry Healy
  • Helen Stevens
  • Yanina Balabanova
  • Francis Drobniewski
  • John A. Todd
  • Sergey Nejentsev
Original Investigation

Abstract

Recently, the Intracellular pathogen resistance 1 (Ipr1) gene was shown to control susceptibility to Mycobacterium tuberculosis in mice. We examined whether common sequence variants of its human orthologue, the SP110 gene, are associated with susceptibility to tuberculosis in a human population. We resequenced SP110 exons in 96 individuals and identified new polymorphisms. Then, we combined our sequence and HapMap data for 83 distinct polymorphisms and selected tags that capture information for all common variants in the 100 kb region around SP110. We genotyped 29 single nucleotide polymorphisms including seven amino-acid changing variants in 1,912 HIV-negative culture-confirmed adult pulmonary tuberculosis patients and 2,104 adult healthy controls from Russia and found no evidence of association. Our results indicate that common polymorphisms of the SP110 gene have no major effect on susceptibility to tuberculosis in this population.

Supplementary material

439_2006_293_MOESM1_ESM.tif (125 kb)
Supplementary material
439_2006_293_MOESM2_ESM.tif (2.2 mb)
Supplementary material
439_2006_293_MOESM3_ESM.tif (2.2 mb)
Supplementary material
439_2006_293_MOESM4_ESM.tif (2.2 mb)
Supplementary material
439_2006_293_MOESM5_ESM.tif (2.2 mb)
Supplementary material
439_2006_293_MOESM6_ESM.doc (258 kb)
Supplementary material

References

  1. Barrett JC, Fry B, Maller J, Daly MJ (2004) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 5:5CrossRefGoogle Scholar
  2. Bloch DB, Nakajima A, Gulick T, Chiche JD, Orth D, de La Monte SM, Bloch KD (2000) Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol Cell Biol 20:6138–6146PubMedCrossRefGoogle Scholar
  3. Casanova JL, Abel L (2002) Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20:581–620PubMedCrossRefGoogle Scholar
  4. Chapman JM, Cooper JD, Todd JA, Clayton DG (2003) Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum Hered 56:18–31PubMedCrossRefGoogle Scholar
  5. Comstock GW (1978) Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 117:621–624PubMedGoogle Scholar
  6. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, Melentyev A, Fedorin I (2005) Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 293:2726–2731PubMedCrossRefGoogle Scholar
  7. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677–686PubMedCrossRefGoogle Scholar
  8. Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, Frucht DM, Christel K, von Bernuth H, Jouanguy E, Feinberg J, Durandy A, Senechal B, Chapgier A, Vogt G, de Beaucoudrey L, Fieschi C, Picard C, Garfa M, Chemli J, Bejaoui M, Tsolia MN, Kutukculer N, Plebani A, Notarangelo L, Bodemer C, Geissmann F, Israel A, Veron M, Knackstedt M, Barbouche R, Abel L, Magdorf K, Gendrel D, Agou F, Holland SM, Casanova JL (2006) X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 203:1745–1759PubMedCrossRefGoogle Scholar
  9. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C (2003) Tuberculosis. Lancet 362:887–899PubMedCrossRefGoogle Scholar
  10. International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299–1320Google Scholar
  11. Kramnik I, Dietrich WF, Demant P, Bloom BR (2000) Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci USA 97:8560–8565PubMedCrossRefGoogle Scholar
  12. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770–1773PubMedCrossRefGoogle Scholar
  13. Newport MJ, Nejentsev S (2004) Genetics of susceptibility to tuberculosis in humans. Monaldi Arch Chest Dis 61:102–111PubMedGoogle Scholar
  14. North RJ, Jung YJ (2004) Immunity to tuberculosis. Annu Rev Immunol 22:599–623PubMedCrossRefGoogle Scholar
  15. Pan H, Yan BS, Rojas M, Shebzukhov YV, Zhou H, Kobzik L, Higgins DE, Daly MJ, Bloom BR, Kramnik I (2005) Ipr1 gene mediates innate immunity to tuberculosis. Nature 434:767–772PubMedCrossRefGoogle Scholar
  16. Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149–150PubMedCrossRefGoogle Scholar
  17. Roscioli T, Cliffe ST, Bloch DB, Bell CG, Mullan G, Taylor PJ, Sarris M, Wang J, Donald JA, Kirk EP, Ziegler JB, Salzer U, McDonald GB, Wong M, Lindeman R, Buckley MF (2006) Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease. Nat Genet 38:620–622PubMedCrossRefGoogle Scholar
  18. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A, Krukova E, Golishevskaya V, Erokhin V, Dorozhkova I, Drobniewski F (2005) Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 60:130–135PubMedCrossRefGoogle Scholar
  19. Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald GJ, Waliszewska A, Kessing BD, Malasky MJ, Scafe C, Le E, De JPL, Mignault AA, Yi Z, De TG, Essex M, Sankale JL, Moore JH, Poku K, Phair JP, Goedert JJ, Vlahov D, Williams SM, Tishkoff SA, Winkler CA, De LVFM, Woodage T, Sninsky JJ, Hafler DA, Altshuler D, Gilbert DA, O’Brien SJ, Reich D (2004) A high-density admixture map for disease gene discovery in African Americans. Am J Hum Genet 74:1001–1013PubMedCrossRefGoogle Scholar
  20. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, Barratt BJ, Guja C, Ionescu Tirgoviste C, Savage DA, Dunger DB, Widmer B, Strachan DP, Ring SM, Walker N, Clayton DG, Twells RC, Gough SC, Todd JA (2004) Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53:3020–3023PubMedCrossRefGoogle Scholar
  21. Staden R, Beal KF, Bonfield JK (2000) The Staden package, 1998. Methods Mol Biol 132:115–130PubMedGoogle Scholar
  22. Stead WW, Senner JW, Reddick WT, Lofgren JP (1990) Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 322:422–427PubMedCrossRefGoogle Scholar
  23. Thye T, Browne EN, Chinbuah MA, Gyapong J, Osei I, Owusu Dabo E, Niemann S, Rusch Gerdes S, Horstmann RD, Meyer CG (2006) No associations of human pulmonary tuberculosis with Sp110 variants. J Med Genet 43Google Scholar
  24. Tosh K, Campbell SJ, Fielding K, Sillah J, Bah B, Gustafson P, Manneh K, Lisse I, Sirugo G, Bennett S, Aaby P, McAdam KP, Bah Sow O, Lienhardt C, Kramnik I, Hill AV (2006) Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc Natl Acad Sci USA 103:10364–10368PubMedCrossRefGoogle Scholar
  25. Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring SM, McArdle W, Pembrey ME, Strachan DP, Dunger DB, Twells RC, Clayton DG, Todd JA (2005) Localization of a type 1 diabetes locus in the IL2RA/CD25 Region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76:5CrossRefGoogle Scholar
  26. Watashi K, Hijikata M, Tagawa A, Doi T, Marusawa H, Shimotohno K (2003) Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus. Mol Cell Biol 23:7498–7509PubMedCrossRefGoogle Scholar
  27. Yan BS, Kirby A, Shebzukhov YV, Daly MJ, Kramnik I (2006) Genetic architecture of tuberculosis resistance in a mouse model of infection. Genes Immun 7:201–210PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Jeffrey S. Szeszko
    • 1
  • Barry Healy
    • 1
  • Helen Stevens
    • 1
  • Yanina Balabanova
    • 2
  • Francis Drobniewski
    • 2
  • John A. Todd
    • 1
  • Sergey Nejentsev
    • 1
  1. 1.Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, Department of Medical GeneticsUniversity of CambridgeCambridgeUK
  2. 2.HPA Mycobacterium Reference Unit and Clinical TB and HIV Group, Center for Infectious Diseases, Institute for Cell and Molecular SciencesBarts and the London Medical SchoolLondonUK

Personalised recommendations